Medi-Caps Ltd.

BSE: MEDICAPQ523144ISIN INE442D01010

Healthcare
Pharmaceuticals

Share price

₹22.76-1.19 (-4.97%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹42.99
52W low: ₹21.00
Off 52W high: -47.06%
1M return: -10.15%
3M return: -14.92%
6M return: -28.90%
1Y return: -40.59%
20D avg volume: 1,085
50 DMA: ₹25.87
200 DMA: ₹26.69

Key ratios Consolidated

Market cap: ₹28.38 Cr
Current price: ₹22.76
52W high / low: ₹42.99 / ₹21.00
Face value: ₹10.00
P/E: -630.72
P/B: 0.25
EPS (TTM): ₹-0.04
Book value / share: ₹89.36
ROE: —
ROCE: -2.70%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-0.50 Cr
Interest cover: -301.00
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 275.0 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	5.77	2.79	3.45	4.30	2.01	2.69	6.96	4.02	8.30	6.19	—
	0.07	0.05	5.59	0.76	1.53	0.34	2.14	0.16	0.29	0.15	—
	5.84	2.84	9.04	5.06	3.54	3.02	9.10	4.18	8.58	6.34	—
	5.93	5.07	6.01	5.80	5.36	6.51	7.65	6.23	8.27	6.90	—
	2.26	1.40	1.18	1.29	1.28	1.69	2.72	1.39	2.15	3.91	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	1.97	1.91	2.17	1.86	1.85	1.86	2.20	1.78	1.88	1.72	—
	0.00	0.00	0.00	0.00	0.00	0.01	0.03	—	—	—	—
	0.49	0.45	0.50	0.44	0.44	0.44	0.44	0.43	0.43	0.43	—
	1.74	1.42	1.80	1.60	2.46	2.62	2.21	1.66	0.89	1.87	—
	-0.09	-2.23	3.03	-0.74	-1.82	-3.49	1.45	-2.04	0.31	-0.56	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.09	-2.23	3.03	-0.74	-1.82	-3.49	1.45	-2.04	0.31	-0.56	—
	0.00	0.00	-0.01	0.03	0.00	0.00	0.27	0.00	0.00	0.00	—
	-0.09	-2.23	3.04	-0.77	-1.82	-3.49	1.72	-2.04	0.31	-0.56	—
	-0.07	-1.79	2.44	-0.61	-1.46	-2.80	1.38	-1.64	0.25	-0.45	—
Key metrics
	0.40	-1.78	3.53	-0.30	-1.38	-3.04	1.92	-1.61	0.74	-0.13	—
	6.90%	-63.80%	102.30%	-7.00%	-68.70%	-113.00%	27.60%	-40.00%	8.90%	-2.10%	—
	-1.60%	-79.90%	88.10%	-17.90%	-90.50%	-129.70%	24.70%	-50.70%	3.70%	-9.00%	—
	-0.10%	—	2.70%	—	-1.50%	—	1.20%	—	—	—	—
	187.10%	3.70%	-50.40%	7.00%	-75.80%	-56.50%	—	—	—	—	—
	95.10%	36.10%	76.70%	62.30%	-687.10%	-523.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	16.31	12.45	25.48	—
	6.47	8.21	2.73	—
	22.78	20.66	28.21	—
	22.81	23.68	29.05	—
	6.13	5.44	10.17	—
	0.00	0.00	0.00	—
	7.91	7.74	7.58	—
	0.00	0.01	0.03	—
	1.88	1.81	1.72	—
	6.56	8.48	9.07	—
	-0.03	-3.02	-0.84	—
	0.00	0.00	0.00	—
	-0.03	-3.02	-0.84	—
	0.02	0.01	-0.27	—
	-0.05	-3.04	-0.57	—
	-0.03	-2.44	-0.46	—
Key metrics
	1.85	-1.20	0.91	—
	11.34%	-9.60%	3.60%	—
	-0.31%	-24.40%	-2.20%	—
	—	-2.70%	-0.70%	—
	4.02%	-51.10%	—	—
	—	-433.30%	—	—
	—	-7.87	4.74	—
	—	2.31	-8.89	—
	—	0.00	0.00	—
	—	-0.50	-0.41	—
	—	275.0	149.1	—
Balance sheet
	—	115.46	125.42	—
	—	47.02	53.44	—
	—	0.50	0.41	—
	—	6.92	8.79	—
	—	2.94	3.20	—
	—	13.25	12.34	—
	—	27.07	27.96	—
	—	0.48	1.58	—
	—	2.71	3.10	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	111.61	121.28	—
Cash flow
	—	-7.02	5.07	—
	—	7.11	-4.98	—
	—	0.00	0.00	—
	—	0.85	0.33	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.12	0.10	0.53	0.77	1.00	0.00	0.89	0.26	0.97	0.29	—
	0.01	0.00	0.08	0.17	0.01	0.31	0.27	0.09	0.10	0.11	—
	0.13	0.11	0.61	0.95	1.01	0.31	1.16	0.35	1.07	0.40	—
	0.66	0.70	0.94	0.63	0.72	0.71	0.72	0.61	0.63	0.73	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.45	0.54	0.47	0.47	0.46	0.46	0.45	0.46	0.45	0.45	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.05	0.05	0.07	0.04	0.04	0.04	0.04	0.04	0.04	0.04	—
	0.16	0.11	0.40	0.12	0.22	0.21	0.23	0.12	0.13	0.24	—
	-0.53	-0.59	-0.33	0.31	0.29	-0.40	0.44	-0.27	0.45	-0.33	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	-0.53	-0.59	-0.33	0.31	0.29	-0.40	0.44	-0.27	0.45	-0.33	—
	0.00	0.00	-0.01	0.03	0.00	0.00	-0.27	—	—	—	—
	-0.53	-0.59	-0.31	0.28	0.29	-0.40	0.71	-0.27	0.45	-0.33	—
	-0.42	-0.47	-0.25	0.23	0.23	-0.32	0.57	-0.21	0.36	-0.27	—
Key metrics
	-0.48	-0.54	-0.26	0.35	0.33	-0.36	0.48	-0.23	0.49	-0.29	—
	-400.00%	-540.00%	-49.10%	45.50%	33.00%	—	53.90%	-88.50%	50.50%	-100.00%	—
	-441.70%	-590.00%	-58.50%	36.40%	29.00%	—	79.80%	-103.80%	46.40%	-113.80%	—
	-0.80%	—	-0.50%	—	0.40%	—	0.60%	—	—	—	—
	-88.00%	—	-40.40%	196.20%	3.10%	-100.00%	—	—	—	—	—
	-282.80%	-47.50%	-143.70%	203.70%	-35.60%	-21.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1.52	2.31	2.42	—
	0.26	0.58	0.56	—
	1.80	2.88	2.98	—
	2.93	3.01	2.69	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	1.93	1.85	1.81	—
	0.00	0.00	0.00	—
	0.21	0.19	0.16	—
	0.79	0.96	0.72	—
	-1.14	-0.12	0.28	—
	0.00	0.00	0.00	—
	-1.14	-0.12	0.28	—
	0.02	0.01	0.27	—
	-1.15	-0.14	0.56	—
	-0.91	-0.11	0.45	—
Key metrics
	-0.93	0.07	0.44	—
	-61.18%	3.00%	18.20%	—
	-75.66%	-6.10%	23.10%	—
	—	-0.20%	0.40%	—
	-29.30%	-4.50%	—	—
	-448.48%	-125.00%	—	—
	—	-0.72	1.78	—
	—	3.36	3.30	—
	—	0.00	0.00	—
	—	-0.01	-0.05	—
	—	469.3	550.5	—
Balance sheet
	—	67.34	68.03	—
	—	21.14	21.90	—
	—	0.01	0.05	—
	—	2.95	3.66	—
	—	0.02	0.03	—
	—	5.85	5.18	—
	—	2.23	2.10	—
	—	0.00	0.04	—
	—	0.23	0.27	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	66.71	67.34	—
Cash flow
	—	-0.47	1.85	—
	—	0.42	-1.85	—
	—	0.00	0.00	—
	—	0.25	0.07	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -29.30%
Profit YoY (TTM): -448.48%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +4.02%
Profit YoY (TTM): +99.11%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 51.44%

Quarter	September 2026	June 2026
Promoter %	51.44%	51.44%

Holder	Type	Holding	Previous	Change
ALOK K GARG	Promoter	26.26%	26.26%	0.00%
MANISHA GARG	Promoter Group	21.61%	21.61%	0.00%
SANGEETHA S	Public	5.55%	5.55%	0.00%
DHEERAJ KUMAR LOHIA	Public	4.73%	4.73%	0.00%
TRAPTI INVESTMENTS LLP	Promoter Group	2.46%	2.46%	0.00%
MANJU GAGGAR	Public	1.10%	1.10%	0.00%
PALASH GARG	Promoter Group	0.56%	0.56%	0.00%
AKSHIT GARG	Promoter Group	0.37%	0.37%	0.00%
KUSUM MITTAL	Promoter	0.10%	0.10%	0.00%
RAMESH CHANDRA MITTAL	Promoter	0.08%	0.08%	0.00%
GEETIKA AGRAWAL	Promoter Group	0.00%	0.00%	0.00%
NIRMALA MITTAL	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Medi-Caps Ltd.	28	22.76	-630.72	-2.70%	+4.02% TTM	+99.11% TTM	-40.59%

Filings & corporate actions

Recent announcements

Submission of unaudited standalone & Consolidated Financial Results for the quarter & Half year ended 30.09.20264 Nov 2026 · Result / Financial Results
Submission of Unaudited Standalone & Consolidated financial Result for the quarter and half year ended 30.09.20264 Nov 2026 · Board Meeting / Outcome of Board Meeting
Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....28 Oct 2026 · Board Meeting / Board Meeting
Certificate for Compliance under Reg. 74(5) of SEBI (D.P.) Regulation 2018 for the quarter ended 30.09.20267 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The trading window shall remain closed for trading in share of the company from 1st October 2026 till completion of the 48 hours of declaration of unaudited standalone and consolidated ....25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Continues disclosers for events transected and approved with requisite majority of member in 43rd AGM23 Sep 2026 · Company Update / General
Voting Results along with Scrutinizer"s Report of 43rd AGM dated 22nd September, 202623 Sep 2026 · AGM/EGM / AGM
Submission of Proceedings of 43rd Annual General Meeting.22 Sep 2026 · AGM/EGM / AGM
Submission of News paper publication after dispatch of 43rd AGM Notice and Annual Report 2025-26.27 Aug 2026 · Company Update / Newspaper Publication
Information under Regulation 44 of SEBI (LODR) Regulation, 2015 and Section 108 of Companies Act, 2013 regarding E-Voting through electronic mode for the 43rd Annual General Meeting to ....25 Aug 2026 · AGM/EGM / AGM
Intimation for dispatch of letter to those shareholders whose email addresses are not registered with company/registrar & transfer agent/Depository Participants.25 Aug 2026 · Company Update / General
Submission of 43rd Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 201525 Aug 2026 · Others / Reg. 34 (1) Annual Report
Submission of Notice of 43rd Annual General Meeting scheduled to be held on 22nd September, 2026 at 12:30 PM (IST) through Video Conference (VC)/Other audio Visual means (OAVM).25 Aug 2026 · AGM/EGM / AGM
Submission of Newspaper publication regarding information of 43rd Annual General Meeting before dispatch of notice and Annual Report 2025-2619 Aug 2026 · Company Update / Newspaper Publication
Pursuant to the requirement of regulation 30 (5) of SEBI (LODR), Regulation 2015, authorization to the person for the purpose of demining the materiality of event or information and for ....8 Aug 2026 · Company Update / General
Standalone and consolidated un audited results for the quarter ended 30.06.2026 approved by the Board in their 02/2026-27 board meeting held on 06.08.2026. An extract of the same published ....8 Aug 2026 · Company Update / Newspaper Publication
Resignation of Mr. Akshit Garg, From the post of General Manager & Senior management personnel and Mrs. Saloni Garg, from the post of Senior Manager & senior management personnel w.e.f. 06.08.20266 Aug 2026 · Company Update / Change in Management
Appointment of Mrs. Saloni Garg as additional and Whole time woman director of the company w.e.f. 07.08.20266 Aug 2026 · Company Update / Change in Management
Appointment of Mr. Alok K. Garg as chairman cum Managing Director of the Company w.e.f. 01.09.20266 Aug 2026 · Company Update / Change in Management
Appointment of Mr. Akshit Garg as Chief Financial officer (CFO) of the Company w.e.f. 07.08.20266 Aug 2026 · Company Update / Change in Management
Submission of unaudited standalone and consolidated financial results for the quarter ended on 30.06.2026 as approved by The board of the directors in its meeting held on 06.08.20266 Aug 2026 · Result / Financial Results
Outcome of the meeting of the board of directors held on 06.08.20266 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation received for resignation of Mr. Ramesh Chandra Mittal as a chairman of the company.30 Jul 2026 · Company Update / Resignation of Chairman
Intimation for resignation of Non executive director Mr. Ramesh Chandra Mittal and Kusum Mittal .30 Jul 2026 · Company Update / Resignation of Director
Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....30 Jul 2026 · Board Meeting / Board Meeting
Certificate for compliance of Reg. 74(5) of SEBI (DP) Regulation 2018 for the quarter ended 30.06.20266 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Trading window shall remain closed for the trading of the share of the company form 1st July 2026 till the completion of 48 hours of declaration of un-audited financial results for ....25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Please find enclosed intimation regarding resignation of Chief Financial Officer.8 Jun 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
Annual Secretarial Compliance Report for F. Y. 2025-2623 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Standalone and consolidated audited financial results for the quarter and year ended 31.03.2026 approved by the Board in their 01/2026-27 Board meeting held on 21.05.2026.An extract of ....23 May 2026 · Company Update / Newspaper Publication
Re-appointment of internal Auditor for the financial year 2026-2721 May 2026 · Company Update / Change in Management
Submission of audited standalone and consolidated financial results for the quarter and year ended 31.03.202621 May 2026 · Result / Financial Results
With reference to the above captioned subject and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that, Board ....21 May 2026 · Board Meeting / Outcome of Board Meeting
Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone ....14 May 2026 · Board Meeting / Board Meeting
Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 regarding intimation to the shareholders holding shares in physical mode for mandatory furnishing of PAN, KYC, Bank and other details.5 May 2026 · Company Update / General
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....8 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Information for shareholders regarding opening of Special window for Transfer and Dematerialization of Physical Securities.4 Apr 2026 · Company Update / General
Submission of certificate under regulation 74(5) of SEBI (DP) Regulation, 2018 for the quarter and year ended 31.03.2026.4 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The trading window shall remain close for the trading of the shares of the company from 01.04.2026 till the completion of 48 hours of declaration of audited financial results for the quarter ....25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Extract of un-audited standalone and consolidated financial results of the company for the quarter and nine month ended on 31.12.2025 published in Free press journal English edition and ....13 Feb 2026 · Company Update / Newspaper Publication

Board meetings

4 Nov 2026 Board Meeting - Financial Results
6 Aug 2026 Board Meeting - Financial Results